Rockefeller Capital Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-540
Closed -$4K 4078
2022
Q4
$4K Buy
540
+290
+116% +$5.67K ﹤0.01% 3411
2022
Q3
$8K Buy
+250
New +$9.27K ﹤0.01% 3207
2022
Q2
Sell
-90
Closed -$9K 4471
2022
Q1
$9K Hold
90
﹤0.01% 3129
2021
Q4
$22K Sell
90
-1,160
-93% -$258K ﹤0.01% 2612
2021
Q3
$245K Sell
1,250
-225
-15% -$44.9K ﹤0.01% 1515
2021
Q2
$295K Sell
1,475
-695
-32% -$141K ﹤0.01% 1371
2021
Q1
$440K Buy
+2,170
New +$472K ﹤0.01% 1062

Other funds holding SNCE

Rockefeller Capital Management's SNCE Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2023, closing a stake of 540 shares — an estimated $4K sold.

Rockefeller Capital Management first reported a position in SNCE in Q1 2021 and held it in 7 quarters. The position peaked at $440K in Q1 2021. 56 funds tracked by Wall St. Rank hold SNCE as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 540 Science 37 Holdings, Inc. Common Stock shares in Q1 2023, an estimated $4K.
  • Rockefeller Capital Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Rockefeller Capital Management's Science 37 Holdings, Inc. Common Stock position peaked at $440K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.